emodin has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Brattain, MG; Sabbah, DA; Simms, NA; Vennerstrom, JL; Zhong, H | 1 |
| Huang, Q; Ong, CN; Shen, HM | 1 |
| Kim, SH; Lee, SU; Min, YK; Shin, HK | 1 |
| Choi, JY; Choi, YH; Kim, HN; Kim, SH; Kim, YS; Kwak, HB; Lee, SU; Lim, KE; Min, YK; Park, SJ; Rhee, M | 1 |
| Jackson, TC; Kochanek, PM; Verrier, JD | 1 |
6 other study(ies) available for emodin and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Stereoisomerism; Structure-Activity Relationship | 2012 |
Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway.
Topics: cdc42 GTP-Binding Protein; Cell Line, Tumor; Cell Movement; Chromones; Cytoskeleton; Dose-Response Relationship, Drug; Emodin; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; Humans; Morpholines; p21-Activated Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Plasmids; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pseudopodia; rac1 GTP-Binding Protein; Signal Transduction; Transfection | 2005 |
Emodin accelerates osteoblast differentiation through phosphatidylinositol 3-kinase activation and bone morphogenetic protein-2 gene expression.
Topics: 3T3 Cells; Alkaline Phosphatase; Animals; Anthraquinones; Blotting, Western; Bone Morphogenetic Protein Receptors, Type II; Cell Differentiation; Chromones; Cloning, Molecular; Coloring Agents; Emodin; Enzyme Activation; Enzyme Inhibitors; Genes, Reporter; Luciferases; Mice; Morpholines; Osteoblasts; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; RNA, Messenger; Transfection | 2008 |
Physcion-8-O-beta-D-glucopyranoside enhances the commitment of mouse mesenchymal progenitors into osteoblasts and their differentiation: Possible involvement of signaling pathways to activate BMP gene expression.
Topics: Animals; Blotting, Western; Bone Morphogenetic Protein 2; Cell Differentiation; Cell Line; Chromones; Emodin; Glucosides; Mesenchymal Stem Cells; Mice; Morpholines; Osteoblasts; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Polymerase Chain Reaction; Promoter Regions, Genetic; Signal Transduction | 2010 |
Anthraquinone-2-sulfonic acid (AQ2S) is a novel neurotherapeutic agent.
Topics: Animals; Anthraquinones; Apoptosis; Caspases; Cell Survival; Cells, Cultured; Chromones; Emodin; Hydrogen Peroxide; Lipid Peroxidation; Morpholines; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Staurosporine | 2013 |